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Introduction
Developing vertebrate telencephalon comprises two major regions: the pallium and the subpallium. The pallium gives rise to the cerebral cortex and hippocampus, whereas the subpallium generates basal ganglia (Puelles et al. 2000; Wilson and Rubenstein 2000; Marin and Rubenstein 2001) . All these structures are essential for integration of the various sensory information and then formulating of a behavioral response. Within the telencephalon, cerebral cortex, especially the neocortex, is the newest evolved brain region, which is believed to hold all the secrets to make us human and be the center of human-specific cognitive abilities (Adolphs 2003; Rakic 2009; Radonjic et al. 2014) . Fully dissecting out the molecular mechanisms controlling telencephalic development is a major task in developmental biology, which will promise to yield insights into the pathology of developmental disorders and therefore derive of therapeutic strategies for these devastating diseases.
Generation of various telencephalic neuroprogenitors (NPs) involves 2 key steps, neural induction followed by regional patterning along both the anteroposterior (AP) and dorsoventral (DV) axes (Sasai and DeRobertis 1997; Wilson and Rubenstein 2000) . It is now widely accepted that neural AP patterning follows an activation/transformation model initially proposed by Nieuwkoop (Nieuwkoop and Nigtevecht 1954; Stern 2001; Levine and Brivanlou 2007) . In this model, neural fate is induced and a prospective forebrain regional identity is also achieved (activation) simultaneously. During the patterning stage, caudalization signals, such as Wnts, retinoic acid (RA) and fibroblast growth factors (FGFs), generate posterior progenitors from the uncommitted cells bearing a primitive forebrain identity (transformation) (Cox and Brivanlou 1995; Mcgrew et al. 1995; Blumberg et al. 1997) . The activation/transformation model coincides with the finding that epiblast cells and NE cells uniformly express of Otx2, a transcription factor important for forebrain and midbrain specification (Rhinn et al. 1998; Foley et al. 2000) . Moreover, the activation/transformation model is also strongly supported by the studies from both mouse and human embryonic stem cells (ESCs). When human and mouse ESCs are in vitro differentiated into a NE fate, they automatically adopt a telencephalic fate in the absence of any patterning morphogens (Zhang et al. 2001; Ying et al. 2003; Li et al. 2005; Pankratz et al. 2007; Gaspard et al. 2008; Chambers et al. 2009 ). However, these NE cells preserve their patterning potency and are easily caudalized in the presence of Wnts and/or RA (Wichterle et al. 2002; Li et al. 2005; Watanabe et al. 2005; Pankratz et al. 2007; Du et al. 2015) .
Regional identity along the DV axis is almost concomitantly established, while the neural tube gets AP patterned (Wilson and Rubenstein 2000) . It still remains unclear how cerebral cortex and basal ganglia are specified from the telencephalic NPs dorsoventrally, although a body of evidence shows that morphogens and transcription factors may play a role. Studies using chick explant cultures reveal that Wnts (Wnt3a), but not BMPs, convert the ventral telencephalic cells into the dorsal telencephalic fate (Sussel et al. 1999; Gunhaga et al. 2003) . Activation of Wnts signaling in the mouse ventral telencephalon also represses the subpallium development (Backman et al. 2005) . Ablation of β-catenin in the telencephalon results in downregulated expression of dorsal genes while misexpressing of ventral genes dorsally (Backman et al. 2005) . Therefore, Wnts/β-catenin signaling may play an instructive role in either specifying or maintaining the dorsal identity of the telencephalon. On the other hand, studies from chick embryos and transgenic mice suggest that sonic hedgehog (Shh) emanating from the node and the prechordal plate defines the forebrain ventral fate (Gunhaga et al. 2000; Fuccillo et al. 2004) . In Shh null mouse, all ventral telencephalic NPs are missing as assessed by a loss of expression of all ventral markers including Nkx2.1, Dlx2, and Gsx2 (Chiang et al. 1996; Ohkubo et al. 2002; Rallu et al. 2002; Fuccillo et al. 2004 ). Conversely, ectopic activation of the Shh pathway induces these ventral genes expressed in the dorsal telencephalon of zebrafish and mice (Barth and Wilson 1995; Ericson et al. 1995; Chiang et al. 1996; Shimamura and Rubenstein 1997) . Wnts and Shh set up DV domains in the telencephalon through tight regulation of region-specific transcription factors, in particular, Pax6 and Nkx2.1.
Pax6 is mainly expressed in the dorsal forebrain, and its loss of function results in abnormal expression of ventral marker genes in the dorsal territory (Toresson et al. 2000) . Nkx2.1 is expressed in the medial ganglionic eminence (MGE), which derives caudate-putamen and globus pallidus (Xu et al. 2004) . Loss of Nkx2.1 results in a ventral to dorsal respecification as evidenced by extended expression of Pax6 in the MGE region (Sussel et al. 1999) .
It is currently unknown whether the DV patterning of the forebrain is cross-regulated by multiple organizing centers, which reside in the most dorsal and ventral midlines of a developing brain and emanate Wnts and Shh, respectively, or follows an activation/transformation model, in which a regional dorsal or ventral identity will first be activated automatically but transforms to the other in response to reverse patterning morphogens. We recently identified that Pax6 is uniformly expressed in the NE within the early human fetus before neural tube closure . And this early Pax6 expression efficiently converts the epiblast into a NE fate in human ESCs . As the most important dorsalization transcription factor, expression of Pax6 in human NE makes us hypothesize that DV patterning of human forebrain follows an activation/transformation model. In this study, we are going to prove this model and investigate how a forebrain dorsal fate is automatically activated during human neural induction and how Shh ventralizes a prospective dorsal fate into ventral telencephalic progenitors in human ESCs.
Results

Modeling Human Forebrain DV Patterning Through In Vitro Neural Differentiation of Human ESCs
As a valid and unprecedented model to study early human neural development, human ESCs could be efficiently differentiated into NE and then various regional NPs in vitro (Li et al. 2005 (Li et al. , 2008 (Li et al. , 2009 Chambers et al. 2009; Zhang XQ and Zhang SC 2010; Liu, Weick, et al. 2013 ). We first modeled human forebrain DV patterning in vitro though ESCs. Human ESCs were lifted from the culture surface and suspended in the ESC culture medium for 4 days to initiate differentiation and then switched to the neural induction medium (NIM) for neural lineage specification Zhang XQ and Zhang SC 2010) . With this neural differentiation protocol, human ESCs adopted a NE fate after 8-10 days of differentiation as demonstrated by uniform Pax6 and Sox2 expression, which was consistent with their expression pattern in early human fetuses ( Fig. 1A ; . At Days 14-25, the differentiation derivatives expressed Sox2, Pax6, and Sox1, representing late stage neuroepithelium (Fig. 1A) . Unlike Day 10 NE, Days 17-25 cells lost their regional patterning potency along either AP or DV axes (Li et al. 2005; Pankratz et al. 2007 ). The retained Pax6 expression in these cells indicates that at Days 17-25, the late stage neuroepithelial cells are already committed to forebrain dorsal NPs. When Shh were applied from Day 10, the differentiated neuroepithelia at Day 14 gradually lost Pax6 with increased Nkx2.1 expression. At Days 17-25, the cells were almost completely Nkx2.1 positive with no Pax6 expression, suggesting efficient dorsal to ventral fate transformation implemented by Shh (Fig. 1B) .
Consistent with the staining data, the pluripotent gene Oct4 was quickly downregulated during neural differentiation at the mRNA level (Fig. 1A,C ). Sox2 is a transcription factor specifically expressed in both pluripotent and neuroepithelial cells. During neural differentiation, Sox2 was maintained at a high level (Fig. 1A,C) . Combined with the gradually elevated expression of Sox1, all these data indicate the efficient activation of a NE fate from human ESCs. Foxg1 is a specific telencephalic gene and its mRNA was detected as early as Day 10 and maintained thereafter (Fig. 1C) . In contrast, En1 and Hoxb4, markers specific for midbrain and hindbrain or spinal cord identities, respectively, were undetected (Fig. 1C) . These results indicate that human ESCs pick up a telencephalic fate in the absence of exogenous patterning morphogens, which is in line with the activation/transformation AP patterning model.
Pax6 mRNA was maintained and greatly elevated at Days 17-25 after differentiation in the absence of ectopic patterning morphogens, while Nkx2.1 was not expressed (Fig. 1D,E) , further suggesting a dorsal telencephalic NP phenotype. In striking contrast, Shh treatment showed predominant expression of Nkx2.1 and Gli1 with repressed Pax6 and Gli3 expression ( Fig. 1D-F) , suggesting efficient generation of ventral telencephalic NPs. This was further supported by the repression of Tbr1 and Fezf2, key genes for dorsal progenitors (Fig. 1G ). Together, results obtained above strongly suggest the successfulness of establishing a telencephalic DV patterning model in human ESCs, which mirrors in vivo developmental principles obtained in model organisms such as mice and chicken (Fig. 1H ).
Wnts/β-Catenin Signaling Potentiates Dorsal Gene Expression but is not Necessary for Consolidating of the Default Dorsal Telencephalic Fate
The aforementioned anterior dorsal fate of neuroepithelial cells differentiated from human ESCs without ectopic dorsalization morphogens may originate from endogenous Wnts signaling. Indeed, when Wnt3a, an activator of canonical Wnt signaling expressed in dorsal forebrain midline cells (Parr et al. 1993 ; Harrison-Uy and Pleasure 2012), was added to the NE cells from Days 10 to 17, the expression of Pax6 was significantly elevated ( Fig. 2A, B,D) . Treatment of the cultures with the Wnts signaling antagonist, IWP2, for the same period, exerted a small but significant decrease in Pax6 mRNA expression, further suggesting the contribution of endogenous Wnts signaling in Pax6 expression (Fig. 2D) . Cyclopamine, an inhibitor of Shh signaling pathway, failed to potentiate Pax6 expression, indicating the quiescent state of the endogenous Shh signaling pathway (Fig. 2D ). Shh treatment repressed Pax6 while potentiated Nkx2.1 expression as expected ( Fig. 2A-E ). Quite surprisingly, Shh equally initiated Nkx2.1 but concomitantly repressed Pax6 expression even when exogenous Wnt3a was supplied ( Fig. 2A-E ). These data suggest that the activation of Wnts signaling is not sufficient to repress Shh-induced ventralization and Shh-mediated ventralization is not through antagonizing of the endogenous Wnts pathway.
In the canonical Wnts signaling pathway, the stabilized cytoplasmic β-catenin translocates to the nucleus to bind to Tcf/Lef (lymphoid enhancer binding factor) transcription factors, converting them from repressors to activators of their target genes (Willert and Nusse 1998; Pinson et al. 2000) . To better understand the function of Wnts signaling on DV patterning, we knocked out β-catenin in human ESCs (Liu et al., unpublished data; Fig. 2F) . Knockout (KO) of β-catenin delayed the upregulation of Pax6 during neural differentiation (Fig. 2G ). Although the expression of Pax6 was reduced slightly, immunostaining data showed that the neuroepithelial cells with β-catenin KO were still Pax6 + / Nkx2.1 − , suggesting the default dorsal fate remained (Fig. 2H) .
Moreover, the β-catenin KO NE still preserved its patterning potency in response to Shh treatment. Shh addition efficiently ventralized the NE into MGE NPs as shown by turning off Pax6 while upregulating of Nkx2.1 expression at both the protein and mRNA levels ( Fig. 2H,I ). We next established a constitutive active β-catenin (S33Y) doxycycline inducible overexpression (iOE) human ESC line. Doxycycline (Dox) addition under both control and Shh-treated conditions from Days 10 to 17 elevated β-catenin mRNA expression (Fig. 2J) . Meanwhile, the expression of Dkk1 and Fgf20, 2 well-studied β-catenin downstream genes (Katoh and Katoh 2007) , was significantly induced, suggesting efficient activation of the canonical Wnts signaling pathway (Fig. 2K,L ).
In the presence of Dox, Shh again induced Nkx2.1 and Gli1 while repressed Pax6, Fezf2, and Tbr1 expression ( Fig. 2M,N) . Therefore, the default forebrain dorsal fate of human NE could not be attributed to the activation of endogenous Wnts/β-catenin signaling. Human ESCs-derived NE will automatically adopt an anterior dorsal regional identity no matter in the presence or the absence of Wnts/β-catenin signaling. Moreover, Shh represents a dominant positive ventralization morphogen even when Wnts/β-catenin signaling is activated (Fig. 2O ).
Removal of Pax6 Expression is a Prerequisite for Efficient Ventralization Mediated by Shh
Since Shh efficiently ventralized human NE into ventral telencephalic NPs even when Wnts/β-catenin signaling was activated, suggesting Shh could override Wnts in ventral patterning (Fig. 2) . We therefore asked whether Pax6 needs to be downregulated before efficient ventralization. To this end, we constructed a Pax6 iOE human ESC line (Fig. 3A) . When Dox was added to the medium from Day 10 NE, the expression of Pax6 was elevated by 3-fold and the NPs normally maintained a Pax6 + /Nkx2.1 − dorsal telencephalic identity at Day 25 ( Fig. 3B-D) . Again, Shh efficiently patterned NE to a MGE fate without Dox treatment (Fig. 3B) . However, forced expression of exogenous Pax6 now blocked ventralization mediated by Shh, as evidenced by lack of Nkx2.1 expression in those Pax6 positive cells (Fig. 3B) . Dox treatment in the Shh group also exhibited higher expression of Pax6 and lower expression of Nkx2.1 at the mRNA level, further supporting the idea that Pax6 overexpression hinders Shh-induced ventralization (Fig. 3C,D) . After a longer period of culture, the expression of Shh mRNA, a hallmark of subventricular zone of the MGE, also showed significant reduction at Day 25, further suggesting ineffectiveness in ventral patterning (Fig. 3E ). Lhx6 and Lhx8, the LIM-homeobox containing transcription factors expressed in MGE NPs, are assumed to play specific roles in defining the MGE territory and are proposed to be crucial in specifying GABA and cholinergic neuronal subtypes, respectively (Zhao Manabe et al. 2005; Flames et al. 2007 ). As expected, both Lhx6 and Lhx8 were expressed at extremely low levels when Pax6 was forced expressed (Fig. 3F,G) . As downstream genes of Shh signaling, Gli1 and Gli3 mRNAs were similarly induced or repressed by Shh treatment in the presence of Doxinduced Pax6 overexpression, suggesting the integrity of the Shh signaling pathway (Fig. 3H,I ). Thus, Pax6 works as a dorsal identity gatekeeper, which represses the expression of ventral genes, such as Nkx2.1 (Fig. 3J) . It is more likely that Shh needs to downregulate Pax6 first before it can make an efficient ventral transformation.
Knockout of Pax6 is not Sufficient to Convert Dorsal Telencephalon to MGE
We next analyzed whether removal of Pax6 expression is sufficient to make a dorsal to ventral transformation. For this purpose, a gRNA specifically targeting Pax6 was designed to make a double strand break when co-electroporated into human ESCs together with the Cas9 vector (Fig. 4A) . A donor plasmid was also electroporated to the cells to substitute the open reading frame of Pax6 into CreERT through homologous recombination. Genotyping, immunostaining, and qPCR analyses were used to confirm the homozygous recombination and Pax6 knockout (Pax6 KO) efficiency (Fig. 4C,E) . As shown in Figure 4B , Pax6 KO showed severely hindered neural differentiation as demonstrated by dark embryoid bodies (EBs) and lower attachment ability on laminin-coated culture surface, which resembled Pax6 RNAi phenotypes . Treatment of the cells with SB431542 and DMH1 from Days 1 to 7 to inhibit both TGFβ and BMPs pathways efficiently rescued the neural differentiation deficits of Pax6 KO cells. The cells could now normally attach to the laminin-coated culture surface and showed clear neural rosettes at Day 10 NE. At Day 25, Pax6 KO cells showed no Pax6 immunosignals and they were also absent of Nkx2.1 expression, suggesting no autonomous DV conversion occurred (Fig. 4C) . Albeit Pax6 was not present, the Day 25 differentiation derivatives of Pax6 KO cells still remained as dorsal telencephalic NPs, since Tbr1 and Fezf2, the 2 definitive cortical hallmark genes, were regularly expressed as in the WT counterpart ( Fig. 4F,G ; Campbell 2003; Wang et al. 2011 ). In addition, Pax6 KO cells were normally patterned to a ventral telencephalic fate when exposed to Shh at Days 10-17. As shown in Figure 4D , the ventralized cells were now Pax6 − /Nkx2.1 + . More importantly, their ventral fate was also evidenced by repressed Tbr1 and Fezf2 expression while increased Nkx2.1, Shh, and Lhx6 expression ( Fig. 4H-J) . We therefore conclude that ablation of Pax6 is not sufficient to accomplish a DV transformation, although downregulation of Pax6 proceeds ventral telencephalic parcellation from a primitive dorsal identity. The whole dorsal genetic context, which may include expression of Pax6, Tbr1, Fezf2, or other cortical transcription factors, preserves the NE in a prospective dorsal identity (Fig. 4K ).
Forced Expression of Nkx2.1 is not Sufficient to Make a Dorsal to Ventral Transformation
We next constructed Nkx2.1 iOE human ESC line through the same system used for Pax6 iOE (Fig. 5A) . Under the control conditions, Nkx2.1 iOE human ESCs normally differentiated into NE and then Pax6 + /Nkx2.1 − dorsal telencephalic NPs (Fig. 5B) . In addition, Nkx2.1 iOE human ESCs were easily ventralized by Shh exposure, by greatly downregulated Pax6, Tbr1, and Fezf2 expressions while concomitantly increased Nkx2.1, Lhx6, and Lhx8 expressions ( Fig. 5D-I ). These data indicate that the constructed Nkx2.1 iOE human ESC line is phenotypically normal as of wild-type human ESCs in neural induction as well as regional patterning. Dox addition from Days 10 to 25 clearly induced ectopic Nkx2.1 expression at both the protein and mRNA levels (Fig. 5C,D) . While in the absence of Shh treatment, overexpression of Nkx2.1 could not downregulate endogenous Pax6 and now the NPs were double positive for Pax6 and Nkx2.1 (Fig. 5C ). It was noteworthy that the Pax6 + /Nkx2.1 + NPs still represented a dorsal telencephalic fate, given their high-level expression of Pax6, Tbr1, and Fezf2, and extremely low-level expression of Lhx6 and Lhx8 (Fig. 5E-I) . Thus, forced expression of Nkx2.1 is not sufficient to suppress the dorsal genes and bring the primitive dorsal neuroepithelial cells into a ventral telencephalic fate without Shh exposure (Fig. 5J) . Du et al. (2008) reported that Nkx2.1 could activate Lhx6 expression during interneuron specification. In our current study, without Shh treatment, Lhx6 was only marginally induced by forced expression of Nkx2.1. This indicates that a ventral cell context may be required for Nkx2.1 to fully activate Lhx6 and therefore guide GABA neuron specification.
Nkx2.1 is not Necessary for Shh Triggered Ventralization
To further test the role of Nkx2.1 in forebrain DV patterning, we constructed Nkx2.1 knockout (Nkx2.1 KO) human ESC line through substitution of the coding exons into a drug selection gene expression cassette (Fig. 6A ). Nkx2.1 KO cells showed similar neural induction efficiency and were committed into a dorsal telencephalic fate by default (Fig. 6B ). Nkx2.1 could not be identified at either the protein or the mRNA level in the KO cells treated with Shh, confirming the KO efficacy (Fig. 6C,D) . Strikingly, ablation of Nkx2.1 expression could not prevent Shh triggered ventralization, since Pax6 and Tbr1 were equally diminished and endogenous Shh was similarly transcribed as with the wildtype control (Fig. 6C ,E-G). Wnt3a addition could not prevent Shh-induced ventralization either in Nkx2.1 KO cells (Fig. 6E-G) . Therefore, we conclude that Nkx2.1 is not absolutely required for Shh-induced ventral patterning of the telencephalon. Although Nkx2.1 was not necessary for ventral patterning, Nkx2.1 KO human ESCs failed to differentiate into the MGE fate upon Shh treatment, given Lhx6 and Lhx8 were now completely missing (Fig. 6H,I ). Foxp2, Nolz1, and Ebf1, specific transcription factors for lateral ganglionic eminence (LGE) progenitors, showed higher expression in Nkx2.1 KO ventral cells ( Fig. 6J ; Garel et al. 1999; Takahashi et al. 2003; Chang et al. 2004; Arber et al. 2015) . Meanwhile, Ascl1, a Shh signaling downstream transcription factor expressed in both MGE and LGE (Voronova et al. 2011; Arber et al. 2015) , was equally expressed in those wild-type and Nkx2.1 KO ventral cells (Fig. 6J) . We therefore conclude that Shh induces a ventral telencephalic fate through repression of those dorsal genes, which act as gatekeepers and suppress ventral telencephalon development (Fig. 6K) . Although Nkx2.1 is not absolutely required for efficient Shh-induced ventralization, ablation of Nkx2.1 expression might switch the MGE fate to other ventral regional identities, such as LGE (Sussel et al. 1999; Butt et al. 2008 ).
Discussion
In this study, we modeled human forebrain DV patterning and studied underlying mechanisms in human ESCs by taking advantage of our sophisticated in vitro neural differentiation system (Li et al. 2009; Hu et al. 2010; Liu, Weick, et al. 2013; Liu, Chi, et al. 2013; Wang et al. 2013) . Our results showed that human ESCs mostly exhibited a primitive forebrain dorsal identity during in vitro neural differentiation in the absence of any ectopic patterning morphogens. The primitive forebrain dorsal fate referred to an uncommitted state, since Shh efficiently converted it into a ventral telencephalic identity. This DV patterning system has been proved to be a highly reproducible neural differentiation system for cortical glutamatergic neuron, GABA inhibitory neuron or basal forebrain cholinergic neuron production from human ESCs (Zhang et al. 2001; Li et al. 2009; Liu, Weick, et al. 2013; Maroof et al. 2013; Cunningham et al. 2014) . In all these studies together with ours, the patterning behavior and regional gene expression profiles largely mirror what have been learned in model organisms, such as chicken and mice (Marti et al. 1995; Gunhaga et al. 2000; Ragsdale and Grove 2001) . Therefore, human ESCs represent a previously unprecedented model system to study early developmental events. We found two unidirectional regulatory trends during human DV patterning in the current study. First, Shh overrides Wnts potentiated dorsal fate. Shh efficiently repressed the dorsal marker genes and subsequently initiated ventralization of the forebrain. However, ectopic activation of Wnts/β-catenin pathway could not interfere with Shh triggered ventralization. Second, Dorsal genes predominantly suppress ventral patterning. Overexpression of Pax6 was sufficient to block Shh-induced ventralization. However, Nkx2.1 expression was neither necessary nor sufficient to make a dorsal to ventral switch. Therefore, human forebrain DV patterning follows a repression release model (double negative). Shh induces ventral gene expression and consolidates a ventral forebrain fate by removal of those dorsal genes, which serve as ventral identity blockers.
During neural induction, a neural fate will be automatically induced in the absence of any exogenous signals, which is referred to a "default" model (Munoz-Sanjuan and Brivanlou 2002; Stern 2005) . BMPs, TGFβ, and Wnts are well recognized as neural inhibitory signals and are important to induce nonneural tissues, such as epidermal and mesendodermal lineages (Stern 2005) . AP patterning of the neural axis almost follows exactly the same model. The NE cells will first adopt a primitive anterior fate without ectopic patterning morphogens, while this anterior fate can be switched to a posterior identity in the presence of caudalization morphogens, such as Wnts, RA, and FGFs Day 25 NPs differentiated from Nkx2.1 iOE human ESCs under control, Dox, or Shh-treated conditions. Data are presented as mean ± SEM. Unpaired two-tailed Student's t-test. **P < 0.01. (J) A representative cartoon shows that forced expression of Nkx2.1 alone is not sufficient to repress the dorsal genes. (Harland and Gerhart 1997; Beddington and Robertson 1999; Stern 2001; Levine and Brivanlou 2007) . Again, we present evidence and prove here that human telencephalic DV patterning also shares a similar paradigm. Human NE will first take a dorsal fate by default but it preserves the patterning potency and gets easily ventralized by Shh exposure. All these 3 key developmental events can be summarized as an activation/ transformation model (Nieuwkoop and Nigtevecht 1954; Stern 2001; Levine and Brivanlou 2007) . The uncommitted cell lineage will first activate an identity by default but it can respond to the signals emanating from organizing centers and get transformed to distinct sibling cell types. Unpaired two-tailed Student's t-test. **P < 0.01. (J) mRNA expression of Ascl1, Foxp2, Nolz1, and Ebf1 in Day 25 NPs differentiated from wild-type or Nkx2.1 KO human ESCs under Shh-mediated ventral conditions. Data are presented as mean ± SEM. Unpaired two-tailed Student's t-test. *P < 0.05, **P < 0.01. (K) A representative cartoon shows that Shh represses the dorsal genes and therefore initiates ventral gene expression in a repression release manner. The ventral hallmark gene, Nkx2.1 does not directly antagonize the dorsal genes, and is neither necessary nor sufficient to convert the primitive dorsal telecephalic fate ventrally, though its expression is crucial for normal MGE development.
The activation/transformation model is interesting if we consider that the dorsal forebrain is the most advanced evolved structure in humans (Rakic 2009 ). It is currently unclear whether this DV model is human specific or conserved among vertebrates. Results obtained from model organisms reveal that Wnts and Shh, Pax6 and Nkx2.1 are antagonized pairs and they are mutually repressed, which is somewhat divergent from our current model learned from human ESCs (Sussel et al. 1999; Gunhaga et al. 2000 Gunhaga et al. , 2003 Lupo et al. 2014 ). More importantly, Pax6, a ventral fate blocker, is uniformly expressed in human NE no matter differentiated from human ESCs or in fetuses around the gastrula stage (Li et al. 2005; Pankratz et al. 2007; . However, Pax6 is completely absent in mouse NE ). Opposite to the human ESCs, NPs differentiated from mouse ESCs mostly take a ventral telencephalic fate and blockage of Shh signaling is necessary to convert it into a cortical identity (Gaspard et al. 2008 ). In the future, it will be extremely interesting for us to investigate whether the activation/transformation DV patterning model is unique for humans and whether this could be related to our more sophisticated cognitive abilities or developmental neural disorders.
Experimental Procedures
Human ESC Culture
Human ESC line H9 (WA09, Passages 25-45, WiCell Agreement No. 14-W0377) was cultured on a feeder layer of irradiated mouse embryonic fibroblasts (MEFs) as previously described (Thomson et al. 1998) . Cells were passaged every 5 days through dispase (Gibco, 17105) digestion. The components of the human ESC culture medium (hESCM) are: DMEM/F12, 20% knockout serum replacer, 1× MEM nonessential amino acids solution, 1× -glutamine solution, 0.1 mM β-mercaptoethanol, and 4 ng/mL FGF2.
Neural Differentiation
The procedure for the neural differentiation system was described previously (Zhang et al. 2001; Zhang XQ and Zhang SC 2010) . Briefly, human ESCs were detached from the MEF layers after dispase digestion. ESC aggregates were then pipetted up and down against the bottom of a 50 mL conical centrifuge tube to break up the colonies into 100-200 µm pieces and suspended in hESCM for 4 days to form EBs. EBs were then switched to the NIM to guide the cells toward the NE fate for 2 days. At Day 6, cell aggregates were plated on laminin-coated culture surface and neural tube-like rosettes could be seen at Days 14-17. For regional patterning, Wnt3a conditioned medium (Li et al. 2009 ), IWP2 (2.5 µM, Stemgent), a combination of Shh and purmorphamine (Li et al. 2008; Liu, Weick, et al. 2013) , and cyclopamine (5 µM, Stemgent) were added to the NE cells from Days 10 to 17. NPs were maintained in suspension culture as neurospheres in NIM. For Pax6 knockout cell lines, SB431542 (2 µM, Stemgent) and LDN193189 (200 nM, Stemgent) were added from Days 1 to 7. The recipe for NIM is as follows: DMEM/F12, 1× N2 supplement, 1× MEM nonessential amino acids solution and 2 µg/mL heparin.
mRNA Extraction and qRT-PCR
Total RNA was isolated by using the Trizol kit (Invitrogen) and RNA concentration was determined by NanoDrop 2000c (Thermo Scientific). cDNA was synthesized using SuperScript III (Invitrogen) and subjected to quantitative RT-PCR (qRT-PCR, Bio-Rad, CFX Connect Real-Time System) using the SsofastEvaGreen kit (Bio-Rad). The housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was amplified as an internal control in gene expression analysis. The primers used for qRT-PCR were as follows: 
Immunocytochemistry and Imaging
Coverslip cultures were fixed in 4% paraformaldehyde for 10 min at room temperature. After adequate washing with PBS, cells were incubated in a blocking buffer (10% donkey serum plus 0.2% Triton X-100 in PBS) for 60 min at room temperature followed by primary antibody incubation at 4°C overnight. On the next day, coverslips were washed with PBS and stained with the fluorescently conjugated secondary antibodies (1:1000, Jackson, West Grove, PA). Nuclei were counterstained with Hoechst 33258. Coverslips were visualized with Leica TSC SP5 (Leica Microsystems, Bensheim, Germany) confocal laser-scanning microscope. Antibodies used in this study included Pax6 (1:1000, mouse IgG, Developmental Studies Hybridoma Bank), Pax6 (1:1000, rabbit IgG, Covance), Nkx2.1 (1:400, mouse IgG, Chemicon), Sox1 (1:1000, goat IgG, R&D), Sox2 (1:1000, goat IgG, R&D), and Oct4 (1:1000, mouse lgG, Santa Cruz).
Western Blotting
Cells were lysed in RIPA + buffer and protein concentrations were measured by BCA kit (Thermo Scientific). After denaturing, 20 µg of total proteins were resolved on 12% SDS-PAGE and blotted with antibodies against β-catenin (1:1000, mouse IgG, BD Transduction Lab) and GAPDH (1:3000, rabbit IgG, Sigma).
Pax6 and Nkx2.1 Knockout Cell Line Construction
The Pax6 targeting donor vector comprised a 817 bp 5′ homology arm, the CreERT cassette, Ef1α promoter-driven BSD resistance gene, and a 800 bp 3′ homology arm. The gRNA targeting sequence was TGAGAGTGGAGGGCCGCGG. The Nkx2.1 targeting donor vector comprised a 930 bp 5′ homology arm, followed by Ef1α promoter-driven BSD resistance gene, and a 643 bp 3′ homology arm. The gRNA targeting sequence was GCGCCGGGCTAAAACAAAC. Human ESCs were pretreated with 1 mM Y27632, a Rho Kinase (ROCK)-inhibitor (Calbiochem), for at least 3 h, digested into single cells with trypsin and electroporated with 5 µg CAS9, 5 µg gRNA targeting plasmid, and 40 µg targeting donor plasmid. Transfected cells were plated on MEF feeder layer supplied with Y27632 and cultured overnight. Medium was changed on the next day and individual colonies were selected with blasticidin (1 mg/mL). Positive clones were identified by genomic DNA PCR. For amplifying the 5′ arm and 3′ arm of Pax6, the following primer sets are used:
Pax6-5′arm-BsmBI-F: AACGTA cgtctcagatc GCTCTGACTCTC ACGTCTGCAC; Pax6-5′arm-BsmBI-R: CTTGAC cgtctccctagc GTTGACAAAGA CACCACCGAGC; Pax6-3′arm-BsaI-F: GTCATA ggtctcagaca GATTGTAACTTC GTCCTAATC; Pax6-3′arm-BsaI-R: GCTGAC ggtctcaggcc CCTGACATACAC AACCCTCAC.
Primer sets for identifying the wild-type and homologously recombinated alleles are as follows:
Pax6-Forward-wt: GAATCAGCTCGGTGGTGTCT; Pax6-Reverse-wt: TTGCATCTGCATGGGTCTAT; Pax6-Forward-hr: CAAAATTTTCCGATCACGAGACTAGC; Pax6-Reverse-hr: CTGCCCGTTCAACATCCTTAG.
For amplifying the 5′ arm and 3′ arm of Nkx2.1, the following primer sets are used:
Nkx2.1-5′arm-BsmBI-F: TGCGTC cgtctcagatc TAAAGAAGG TAGGCGGTGAG; Nkx2.1-5′arm-BsmBI-R: GCTGAC cgtctccgttc GAGTGCCCGT CTGTCTGTT; Nkx2.1-3′arm-BsmBI-F: TGCGTC cgtctcggaca GTCTTCAACAT AACCCACTT; Nkx2.1-3′arm-BsmBI-R: GCTGAC cgtctcaaatt GTATTTCGGTC CTCCACT.
Nkx2.1-Forward-wt: AACCAAGCGCATCCAATCTCAAGG; Nkx2.1-Reverse-wt: TGTGCCCAGAGTGAAGTTTGGTCT; Nkx2.1-Forward-hr: CAAAATTTTCCGATCACGAGACTAGC; Nkx2.1-Reverse-hr: GCTGACCGTCTCAAATTGTATTTCGGTC CTCCACT.
Inducible Overexpression Human ESC Line Construction
For making β-catenin S33Y, Pax6, and Nkx2.1 iOE human ESC lines, we first established an EEF1A1-rtTA line through incorporating a CAG-rtTA-IRES-BSD cassette upstream of the EEF1A1 gene promoter. This locus is selected because EEF1A1 is highly expressed along with the entire neural differentiation process, indicating a universal opening chromosome state (Pankratz et al. 2007 ). The designed sequence for gRNA targeting a region upstream of the EEF1A1 promoter was CGTCGCTGGCGTTTTTCCA. The donor vector for homologous recombination comprised an 828 bp 5′ homology arm, CAG promoter-driven rtTA-IRES-BSD, and an 819 bp 3′ homology arm. Human ESCs were electroporated with 40 µg donor plasmid, 5 µg CAS9, and 5 µg gRNA plasmid. Positive clones were selected with blasticidin (1 mg/mL) for 10-14 days and verified by genomic DNA PCR using the following primers: IRES-F: TTGTATGGGATCTGATCTGG; BSD-R: CCTCTACAAATGTGGTATG GCTG. For inducible overexpression, Pax6a-GFP, Nkx2.1, and β-catenin S33Y cDNA were PCR amplified and subsequently constructed into the pLVX-Tight-Puro vector (Clontech, USA) through BamHI and NotI sites for Pax6a-GFP ), BamHI and EcoRI for Nkx2.1, BamHI, and MluI for β-catenin S33Y. For lentivirus production, 10 µg of lentiviral transfer vector, 7.5 µg of Δ8.9 and 5 µg of VSVG were cotransfected into HEK293FT cells (Invitrogen) cultured in a 10 cm dish using the calcium phosphate precipitation method. Sixteen hours after transfection, fresh-cell culture medium was supplied. After 2 days, the medium containing viral particles was collected and filtered through a 0.45 µm filter (Millipore). The viral particles were further concentrated by ultracentrifugation (SW28 rotor, Beckman) at 50 000 × g for 2.5 h. The pellet was resuspended in hESCM. For transduction, EEF1A1-rtTA human ESC line was passaged normally and pelleted by brief centrifugation. Cell pellets were then incubated with 100 µL of concentrated virus (10 6 transducing units/mL) at 37°C for 30 min. The virus and cell mixture was then transferred to a MEF feeder layer overnight and fresh medium were supplied on the next day. For amplifying the 5′ arm and 3′ arm of EEF1A1, the following primer sets were used: EEF1A1-5′ arm-BsmBI-F: Acgtctcagatc ATAGTAAACGCTTT ATAAATACC; EEF1A1-5′ arm-BsmBI-R: Tcgtctccgttc ATCCATACCACCCA GCTGTTCGC; EEF1A1-3′ arm-BsmBI-F: Acgtctctgaca ACGCCGCTCGAGCC TCCGCA; EEF1A1-3′ arm-BsmBI-R: Tcgtctcaaatt CGGGAGTCTCACCATG TTGGCC.
For amplifying Pax6a-GFP, Nkx2.1, and β-catenin S33Y, the following primer sets were used:
BamHI-Pax6a-GFP-F: GAAC ggatcc TGTAATCTTGGCCAGTA TTG; NotI-Pax6a-GFP-R: GAAC gcggccgc CATATTCGAGCCCCGTG GAATCC; BamHI-Nkx2.1-F: GCTA ggatcc GCGAAGCCCGATGTGGTCCG GAGGCAGTGG; EcoRI-Nkx2.1-R: CGAT gaattc TCACCAGGTCCGACCGTATA; BamHI-β-catenin (S33Y)-F: AGA ggatcc ATGGCTACTCAAGCT GATTTGATGGAG; MluI-β-catenin (S33Y)-R: ACGT acgcgt TTACAGGTCAGTATC AAACCAGGCCA.
For S33Y point mutation of β-catenin, melting PCR was used through the following primers:
β-Catenin (S33Y)-F: CCTGGACTATGGAATCCATTCTGGTGC; β-Catenin (S33Y)-R: GCACCAGAATGGATTCCATAGTCCAGG.
Statistical Analysis
Data were analyzed using Student's t-test for comparison of independent means with pooled estimates of common variances.
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